Results
|
381.
|
|
|
382.
|
|
|
383.
|
|
|
384.
|
|
|
385.
|
|
|
386.
|
|
|
387.
|
|
|
388.
|
Class III beta-tubulin is a marker of paclitaxel resistance in carcinomas of unknown primary site. [electronic resource] by
- Sève, Pascal
- Reiman, Tony
- Lai, Raymond
- Hanson, John
- Santos, Cheryl
- Johnson, Lorelei
- Dabbagh, Laith
- Sawyer, Michael
- Dumontet, Charles
- Mackey, John R
Producer: 20070815
In:
Cancer chemotherapy and pharmacology vol. 60
Availability: No items available.
|
|
389.
|
|
|
390.
|
|
|
391.
|
|
|
392.
|
|
|
393.
|
|
|
394.
|
|
|
395.
|
|
|
396.
|
|
|
397.
|
|
|
398.
|
Phase II study of amrubicin in previously untreated patients with extensive-disease small cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) study. [electronic resource] by
- Yana, Takashi
- Negoro, Shunichi
- Takada, Minoru
- Yokota, Soichiro
- Takada, Yoshiki
- Sugiura, Takahiko
- Yamamoto, Hidehiko
- Sawa, Toshiyuki
- Kawahara, Masaaki
- Katakami, Nobuyuki
- Ariyoshi, Yutaka
- Fukuoka, Masahiro
Producer: 20070730
In:
Investigational new drugs vol. 25
Availability: No items available.
|
|
399.
|
|
|
400.
|
|